688356-98-1

Usage

Uses

Used in Pharmaceutical Research:
Methyl 4-Methylsulfanyl-5-azaindole-2-carboxylate is utilized as a key intermediate in the synthesis of various pharmaceutical compounds. Its unique structure allows it to form stable interactions with biological targets, making it a promising candidate for the development of new drugs.
Used in Organic Synthesis:
Methyl 4-Methylsulfanyl-5-azaindole-2-carboxylate serves as a valuable building block in organic synthesis, enabling the creation of a wide range of chemical products. Its reactivity and functional groups make it suitable for various synthetic routes and transformations.
Used in Agrochemicals:
Methyl 4-Methylsulfanyl-5-azaindole-2-carboxylate may find applications in the agrochemical industry, where it could be used as a precursor for the development of novel pesticides or other agricultural chemicals. Its ability to interact with biological systems makes it a potential candidate for this field.
Used in Materials Science:
In the realm of materials science, Methyl 4-Methylsulfanyl-5-azaindole-2-carboxylate could be employed in the design and synthesis of new materials with unique properties. Its heterocyclic structure and functional groups may contribute to the development of advanced materials for various applications.

InChI:InChI=1/C10H10N2O2S/c1-14-10(13)8-5-6-7(12-8)3-4-11-9(6)15-2/h3-5,12H,1-2H3

Upstream product

• 688356-73-2 methyl (2Z)-2-azido-3-[4-(methylthio)pyridin-3-yl]acrylate 
• 62658-92-8 2-Methylthiopyridine-3-carbaldehyde 
• 688356-97-0 methyl (2Z)-2-azido-3-[2-(methylthio)pyridin-3-yl]acrylate 

Relevant academic research and scientific papers

Method of Treating Pathological Blushing

A method of treating pathological blushing is disclosed wherein the patient is administered a DP receptor antagonist. Compositions containing DP antagonists are also included.

METHOD OF TREATING ATHEROSCLEROSIS, DYSLIPIDEMIAS AND RELATED CONDITIONS

A method of treating atherosclerosis is disclosed wherein nicotinic acid or another nicotinic acid receptor agonist is administered to the patient in combination with a DP receptor antagonist. The DP receptor antagonist is administered to reduce, prevent

METHOD OF TREATING ATHEROSCLEROSIS, DYSLIPIDEMIAS AND RELATED CONDITIONS

A method of treating atherosclerosis, dyslipidemia and related conditions is disclosed wherein a compound of formula I: or a pharmaceutically acceptable salt or solvate thereof is administered to the patient in combination with a DP receptor antagonist. T

NIACIN RECEPTOR AGONISTS, COMPOSITIONS CONTAINING SUCH COMPOUNDS AND METHODS OF TREATMENT

The present invention relates to niacin receptor agonists of formula: (I); as well as pharmaceutically acceptable salts and solvates. The compounds are useful for treating dyslipidemias, and in particular, reducing serum LDL, VLDL and triglycerides, and raising HDL levels. Pharmaceutical compositions and methods of treatment are also included.

NIACIN RECEPTOR AGONISTS, COMPOSITIONS CONTAINING SUCH COMPOUNDS AND METHODS OF TREATMENT

The present invention encompasses compounds of Formula I: as well as pharmaceutically acceptable salts and hydrates thereof, that are useful for treating dyslipidemias. Pharmaceutical compositions and methods of use are also included.

NIACIN RECEPTOR AGONISTS, COMPOSITIONS CONTAINING SUCH COMPOUNDS AND METHODS OF TREATMENT

The present invention encompasses compounds of Formula (I); as well as pharmaceutically acceptable salts and hydrates thereof, that are useful for treating dyslipidemias. Pharmaceutical compositions and methods of use are also included.

The Hemetsberger-Knittel synthesis of substituted 5-, 6-, and 7-azaindoles

A series of substituted 5-, 6-, and 7-azaindoles were prepared via the Hemetsberger-Knittel reaction. In general, better yields were obtained at higher temperatures and shorter reaction times than required for the formation of the analogous indoles, and in some cases, only decomposition occurred below a minimum temperature. The resulting templates offer up to five sites for subsequent functionalization to allow a wide range of chemical diversity. Georg Thieme Verlag Stuttgart.

PYRIDOPYRROLIZINE AND PYRIDOINDOLIZINE DERIVATIVES

Pyridopyrrolizine and pyridoindolizine derivatives are prostaglandin receptor antagonists useful for the treatment of prostaglandin-mediated diseases such as allergic rhinitis, nasal congestion and asthma.

Method of treating atherosclerosis, dyslipidemias and related conditions

A method of treating atherosclerosis is disclosed wherein nicotinic acid or another nicotinic acid receptor agonist is administered to the patient in combination with a DP receptor antagonist. The DP receptor antagonist is administered to reduce, prevent or eliminate flushing that may otherwise occur.